This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
CARLSBAD, Calif., Oct. 22, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today a conference call and live webcast, scheduled for today at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time, to provide a business update in advance of the Company's attendance at the upcoming NASS meeting to be held on October 24
th – 26
th, 2012 in Dallas, Texas.
Conference call and webcast details for today are as follows:
Conference call: (ID# 48352833) - (877) 556-5251 for domestic callers and (720) 545-0036 for international callers.
Live webcast: Alphatec Spine website at
www.AlphatecSpine.com , Investor Relations section. The webcast will be recorded and will remain available on Alphatec Spine's website for at least 30 days.
On today's conference call, the Company will provide an update on the following business topics:
Third quarter 2012 revenue is approximately $46.8 million, or $47.8 million on a constant currency basis, compared to $47.6 million reported in the third quarter of 2011. Total U.S. revenue is $31.0 million, driven by continued strong contributions from the Company's Biologics business. International revenue is approximately $15.9 million, or $16.8 million on a constant currency basis, compared to $14.9 million reported in the third quarter of 2011, reflecting continued strong growth in Japan.
The acquisition of certain assets of Phygen, LLC is nearing completion. The required number of Phygen's members have voted in favor of the transaction and both Phygen and Alphatec Spine have signed the Asset Purchase Agreement. Alphatec Spine anticipates closing the acquisition in the next few weeks.
Alphatec Spine will release its full third quarter results on November 1, 2012 at 1:05 p.m. Pacific Time / 4:05 p.m. Eastern Time. A conference call (ID# 46731968) and live webcast have been scheduled to discuss those results and is scheduled for 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing (877) 556-5251 for domestic callers and (720) 545-0036 for international callers. The live webcast will be available online from the investor relations section of the Alphatec Spine website at
www.AlphatecSpine.com . The webcast will be recorded and will remain available on the investor relations section of Alphatec Spine's website for at least 30 days.
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven products that will help improve the aging patient's quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, the Company also markets its products in over 50 international markets through its affiliate, Scient'x S.A.S., via a direct sales force in France, Italy and the United Kingdom and via independent distributors in the rest of Europe, the Middle East and Africa. In Latin America, the Company conducts its business through its subsidiary, Cibramed Produtos Medicos. In Japan, the Company markets its products through its subsidiary, Alphatec Pacific, Inc. In the rest of Asia and Australia, the Company sells its and Scient'x's products through its and Scient'x's distributors.
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.